Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anna Garbat"'
Autor:
Paweł Pabjan, Piotr Błoniarczyk, Piotr M. Stępień, Anna Garbat, Maciej Włosek, Dorota Zarębska-Michaluk
Publikováno v:
Studia Medyczne, Vol 36, Iss 3, Pp 206-210 (2020)
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) was discovered in Wuhan, China at the end of 2019 and is believed to be the cause of COVID-19 (coronavirus disease 2019). There is some evidence that SARS-CoV-2 infection can be complicated
Externí odkaz:
https://doaj.org/article/80dcc03ba5854a91be9d38c939be85c3
Autor:
Paweł Pabjan, Michał Brzdęk, Magdalena Chrapek, Kacper Dziedzic, Krystyna Dobrowolska, Katarzyna Paluch, Anna Garbat, Piotr Błoniarczyk, Katarzyna Reczko, Piotr Stępień, Dorota Zarębska-Michaluk
Publikováno v:
Viruses, Vol 14, Iss 1, p 96 (2022)
Difficult-to-treat populations with chronic hepatitis C (CHC), in the era of interferon treatment, included patients with liver cirrhosis, kidney impairment, treatment-experienced individuals, and those coinfected with the human immunodeficiency viru
Externí odkaz:
https://doaj.org/article/87f48b47a116482c91fe3c2300c7215c
Autor:
Anna Garbat, Piotr Błoniarczyk, Piotr M. Stępień, Maciej Włosek, Paweł Pabjan, Dorota Zarębska-Michaluk
Publikováno v:
Studia Medyczne, Vol 36, Iss 3, Pp 206-210 (2020)
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) was discovered in Wuhan, China at the end of 2019 and is believed to be the cause of COVID-19 (coronavirus disease 2019). There is some evidence that SARS-CoV-2 infection can be complicated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fca48802251378d4d3c4d7148a4f3cc
https://doi.org/10.5114/ms.2020.99542
https://doi.org/10.5114/ms.2020.99542
Autor:
Paweł, Pabjan, Michał, Brzdęk, Magdalena, Chrapek, Kacper, Dziedzic, Piotr M, Stępień, Katarzyna, Paluch, Anna, Garbat, Piotr, Błoniarczyk, Katarzyna, Reczko, Dorota, Zarębska-Michaluk
Publikováno v:
Polish archives of internal medicine. 131(11)
Introduction: The introduction of direct-acting antivirals (DAAs) has provided us with hope to eliminate hepatitis C virus (HCV) infection as a significant public health problem in the coming years. Objective: Our study aimed to compare the effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7343e1bf3f96a4d5de4e2072a078b45
https://pubmed.ncbi.nlm.nih.gov/34565137
https://pubmed.ncbi.nlm.nih.gov/34565137
Autor:
Anna Garbat, Magdalena Chrapek, Katarzyna Paluch, Dorota Zarębska-Michaluk, Piotr Błoniarczyk, Kacper Dziedzic, Paweł Pabjan, Piotr M. Stępień, Katarzyna Reczko, Michał Brzdęk
Publikováno v:
Polish Archives of Internal Medicine.
Introduction The introduction of direct-acting antivirals (DAA) has provided us with hope to eliminate hepatitis C virus (HCV) infection as a significant public health problem in the coming years. Objective Our study aimed to compare the effectivenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e111053ee49c1d809623eb91bbd5caa5
https://doi.org/10.20452/pamw.16094
https://doi.org/10.20452/pamw.16094